This review paper examines the critical role of clinical trials in drug discovery and development, detailing the different phases from initial safety assessments to post-marketing surveillance. It identifies key challenges such as ethical compliance, participant recruitment, and diversity, proposing technological solutions like AI and big data analytics to enhance efficiency and data quality. The paper also looks ahead to how emerging therapies and the need for global collaboration will shape future clinical trial designs. AI
IMPACT Highlights how AI and big data analytics are transforming clinical trial design and implementation, improving efficiency and data quality in drug discovery.
RANK_REASON The item is a review paper published on arXiv discussing clinical trials and the role of AI. [lever_c_demoted from research: ic=1 ai=0.7]
- arXiv
- CatalyzeX
- DagsHub
- Gotit.pub
- Hugging Face
- phase I clinical trial
- phase II clinical trial
- phase III clinical trial
- phase IV clinical trial
- ScienceCast
- Yichao Zhang
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →